Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.595 USD | -1.39% | +16.35% | +26.84% |
May. 09 | NeuroBo Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 08 | Maxim Initiates NeuroBo Pharmaceuticals With Buy Rating, $10 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.84% | 22.86M | |
+9.87% | 115B | |
+11.92% | 106B | |
-2.59% | 21.96B | |
-12.44% | 21.87B | |
-5.29% | 19.21B | |
-4.01% | 18.08B | |
-38.57% | 17.71B | |
+7.23% | 14.32B | |
+34.82% | 12.42B |
- Stock Market
- Equities
- NRBO Stock
- News NeuroBo Pharmaceuticals, Inc.
- NeuroBo Pharmaceuticals Implements 1-For-30 Reverse Stock Split